Staphylococcus aureus subsp. aureus Rosenbach (ATCC® BAA-1721)

Strain Designations: MSSA476  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations MSSA476
Application
Drug discovery
Isolation
Hyper-virulent community acquired strain isolated in the United Kingdom
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genome Sequenced Strain

Staphylococcus aureus plasmid pSAS, complete genome

Type Strain no
Antibiotic Resistance Methicillin sensitive
Comments
Hyper-virulent community acquired methicillin-susceptible (MSSA) strain
Complete genome sequence strain
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor M Enright
Isolation
Hyper-virulent community acquired strain isolated in the United Kingdom
References

Holden MT, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 101(26): 9786-9791, 2004. PubMed: 15213324

Cross References

Nucleotide (GenBank) : BX571858 Staphylococcus aureus plasmid pSAS, complete genome

Nucleotide (GenBank) : BX571857 Staphylococcus aureus strain MSSA476, complete genome